Insider Trading activities of Amicus Therapeutics, Inc. (FOLD)

Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Amicus Therapeutics, Inc. (FOLD) since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Amicus Therapeutics, Inc. since year 2005. Table 2 shows the detailed insider transactions of Amicus Therapeutics, Inc. since 2005. The reporting company's ticker symbol is FOLD. The reporting company's CIK number is 1178879.
The total value of stock buying since 2005 is $164,300,576.
The total value of stock sales since 2005 is $237,007,057.
The total value of stock option exercises since 2005 is $27,779,222.


 1   2   3   4 
Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Amicus Therapeutics, Inc. (FOLD).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2019-09 0 $0 20,000 $201,040 20,000 $76,400
2019-08 4,945 $49,796 20,000 $250,740 20,000 $76,400
2019-07 0 $0 20,000 $249,460 20,000 $76,400
2019-06 0 $0 25,000 $278,855 25,000 $112,150
2019-05 0 $0 20,000 $270,160 20,000 $76,400
2019-04 0 $0 70,000 $982,820 70,000 $184,600
2019-03 0 $0 20,000 $267,580 20,000 $89,740
2019-02 0 $0 90,000 $1,118,440 90,000 $259,450
2019-01 0 $0 192,769 $2,278,480 182,724 $1,619,628
2018-10 30,000 $380,700 10,000 $122,280 10,000 $24,500
2018-09 670,000 $8,051,000 0 $0 0 $0
2018-07 0 $0 15,000 $234,455 15,000 $55,150
2018-06 0 $0 25,000 $418,000 0 $0
2018-05 0 $0 40,000 $605,225 15,000 $44,650
2018-04 0 $0 75,000 $1,109,655 25,000 $119,250
2018-03 535,827 $7,312,314 21,899 $321,039 21,899 $97,499
2018-01 0 $0 114,866 $1,779,507 114,866 $1,303,765
2017-12 0 $0 148,970 $2,041,225 148,970 $2,041,225
2017-10 0 $0 633,224 $9,094,313 633,224 $9,094,313
2017-09 1,395 $20,032 0 $0 0 $0
2017-07 1,500,000 $18,375,000 0 $0 0 $0
2017-06 0 $0 30,000 $300,000 31,629 $314,318
2017-05 0 $0 59,828 $478,624 0 $0
2017-03 0 $0 49,050 $392,400 0 $0
2017-02 0 $0 25,000 $150,000 0 $0
2017-01 0 $0 25,000 $150,000 100,000 $0
2016-12 511,650 $2,428,535 0 $0 0 $0
2016-11 0 $0 33,546 $243,368 2,858 $22,864
2016-10 0 $0 25,000 $181,250 0 $0
2016-09 0 $0 45,500 $339,041 3,500 $28,000
2016-08 0 $0 1,135,458 $7,739,206 0 $0
2016-07 0 $0 20,916 $146,412 0 $0
2016-06 81,300 $592,410 0 $0 0 $0
2016-01 0 $0 0 $0 150,000 $0
2015-12 0 $0 0 $0 25,000 $0
2015-11 10,000 $102,660 0 $0 0 $0
2015-10 800,000 $5,337,750 21,250 $279,117 34,443 $364,211
2015-09 0 $0 55,737 $962,711 28,237 $473,837
2015-07 0 $0 220,524 $3,297,071 226,774 $3,210,384
2015-06 0 $0 224,645 $3,038,793 209,073 $2,818,138
2015-05 0 $0 130,100 $1,410,313 325,000 $0
2015-04 0 $0 46,167 $554,120 46,167 $554,120
2015-03 0 $0 377,696 $4,347,304 374,280 $4,304,056
2015-01 0 $0 4,667 $42,003 4,667 $42,003
2014-12 89,000 $743,951 89,000 $743,951 0 $0
2014-11 2,165,353 $14,172,824 65,353 $522,824 0 $0
2014-10 57,384 $386,733 11,373,209 $60,258,763 0 $0
2014-09 64,257 $391,401 64,257 $391,401 0 $0
2014-08 91,090 $529,756 91,090 $529,756 0 $0
2014-06 4,000,000 $14,000,000 0 $0 16,491 $10,521
2013-11 1,500,000 $3,000,000 0 $0 0 $0
2013-03 25,000 $85,000 0 $0 0 $0
2012-11 1,665 $7,559 0 $0 0 $0
2012-07 2,949,581 $18,582,360 0 $0 0 $0
2012-03 6,410,308 $36,538,754 0 $0 49,931 $31,955
2011-08 10,000 $42,000 0 $0 0 $0
2011-06 20,000 $120,800 0 $0 0 $0
2011-05 0 $0 2,250 $16,875 2,250 $1,435
2010-03 11,898 $43,903 0 $0 0 $0
2009-11 20,000 $82,600 0 $0 0 $0
2009-07 0 $0 50,000 $546,603 0 $0
2009-06 0 $0 9,998 $101,327 0 $0
2009-03 0 $0 2,502 $25,020 1,000 $5,325
2009-02 0 $0 9,408 $92,977 0 $0
2009-01 0 $0 0 $0 4,924 $3,141
2008-12 0 $0 4,573 $38,985 20,098 $12,822
2008-11 0 $0 70,676 $662,758 0 $0
2008-10 0 $0 96,043 $1,083,800 40,000 $119,240
2008-09 0 $0 78,958 $42,540,664 0 $0
2008-08 0 $0 179,212 $2,806,588 1,401 $892
2008-07 0 $0 125,777 $79,015,299 30,000 $19,110
2008-06 0 $0 15,000 $163,741 0 $0
2008-05 0 $0 10,000 $105,229 0 $0
2008-04 0 $0 41,950 $453,327 20,000 $12,740
2008-03 428,376 $13,714,641 10,000 $100,000 0 $0
2008-02 1,292,086 $12,832,012 35,500 $355,702 22,083 $14,088
2008-01 113,700 $1,138,641 10,000 $103,050 20,000 $12,760
2007-12 0 $0 0 $0 15,000 $9,570
2007-08 60,200 $692,220 0 $0 32,366 $20,649
2007-07 119,000 $1,356,351 0 $0 0 $0
2007-06 281,842 $3,188,873 44,894 $673,410 33,736 $21,523

Table 2. Detailed insider stock purchases, sales, and option exercises of Amicus Therapeutics, Inc. insiders (FOLD)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2019-09-11 Crowley John F (Chairman & CEO) Sale 20,000 10.05 201,040
2019-09-11 Crowley John F (Chairman & CEO) Option Ex 20,000 3.82 76,400
2019-08-23 Whitman Burke W (Director) Buy 4,945 10.07 49,796
2019-08-01 Crowley John F (Chairman & CEO) Sale 20,000 12.54 250,740
2019-08-01 Crowley John F (Chairman & CEO) Option Ex 20,000 3.82 76,400
2019-07-01 Crowley John F (Chairman & CEO) Sale 20,000 12.47 249,460
2019-07-01 Crowley John F (Chairman & CEO) Option Ex 20,000 3.82 76,400
2019-06-03 Crowley John F (Chairman & CEO) Sale 20,000 11.15 223,080
2019-06-03 Crowley John F (Chairman & CEO) Option Ex 20,000 3.82 76,400
2019-06-03 Raab Michael (Director) Sale 5,000 11.15 55,775
2019-06-03 Raab Michael (Director) Option Ex 5,000 7.15 35,750
2019-05-01 Crowley John F (Chairman & CEO) Sale 20,000 13.51 270,160
2019-05-01 Crowley John F (Chairman & CEO) Option Ex 20,000 3.82 76,400
2019-04-05 Barth Jay (Chief Medical Officer) Sale 50,000 14.20 710,200
2019-04-05 Barth Jay (Chief Medical Officer) Option Ex 50,000 2.29 114,500
2019-04-01 Crowley John F (Chairman & CEO) Sale 20,000 13.63 272,620
2019-04-01 Crowley John F (Chairman & CEO) Option Ex 20,000 3.50 70,100
2019-03-01 Crowley John F (Chairman & CEO) Sale 20,000 13.38 267,580
2019-03-01 Crowley John F (Chairman & CEO) Option Ex 20,000 4.49 89,740
2019-02-25 Barth Jay (Chief Medical Officer) Sale 70,000 12.52 876,120
2019-02-25 Barth Jay (Chief Medical Officer) Option Ex 70,000 2.62 183,050
2019-02-01 Crowley John F (Chairman & CEO) Sale 20,000 12.12 242,320
2019-02-01 Crowley John F (Chairman & CEO) Option Ex 20,000 3.82 76,400
2019-01-22 Campbell Bradley L (Chief Operating Officer) Sale 36,000 11.81 425,124
2019-01-22 Campbell Bradley L (Chief Operating Officer) Option Ex 36,000 10.36 372,960
2019-01-16 Do Hung (Chief Science Officer) Sale 36,669 12.05 441,861
2019-01-16 Do Hung (Chief Science Officer) Option Ex 35,024 4.04 141,321
2019-01-15 Do Hung (Chief Science Officer) Sale 16,600 12.00 199,200
2019-01-15 Do Hung (Chief Science Officer) Option Ex 8,200 4.04 33,087
2019-01-15 Crowley John F (Chairman & CEO) Sale 103,500 11.71 1,212,295
2019-01-15 Crowley John F (Chairman & CEO) Option Ex 103,500 10.36 1,072,260
2018-10-15 Baird William D Iii (Chief Financial Officer) Sale 10,000 12.23 122,280
2018-10-15 Baird William D Iii (Chief Financial Officer) Option Ex 10,000 2.45 24,500
2018-10-03 Edelman Joseph (10% Owner) Buy 30,000 12.69 380,700
2018-09-24 Edelman Joseph (10% Owner) Buy 20,000 12.45 249,000
2018-09-21 Edelman Joseph (10% Owner) Buy 50,000 12.53 626,500
2018-09-13 Edelman Joseph (10% Owner) Buy 100,000 11.74 1,174,000
2018-09-12 Edelman Joseph (10% Owner) Buy 500,000 12.00 6,001,500
2018-07-02 Andrews Kurt J. (SVP, Human Resources) Sale 5,000 15.63 78,165
2018-07-02 Andrews Kurt J. (SVP, Human Resources) Option Ex 5,000 6.13 30,650
2018-07-02 Baird William D Iii (Chief Financial Officer) Sale 10,000 15.63 156,290
2018-07-02 Baird William D Iii (Chief Financial Officer) Option Ex 10,000 2.45 24,500
2018-06-01 Do Hung (Chief Science Officer) Sale 25,000 16.72 418,000
2018-05-16 Do Hung (Chief Science Officer) Sale 25,000 15.00 375,000
2018-05-16 Mcglynn Margaret G (Director) Sale 10,000 16.00 160,000
2018-05-16 Mcglynn Margaret G (Director) Option Ex 10,000 3.32 33,200
2018-05-14 Barth Jay (Chief Medical Officer) Sale 5,000 14.04 70,225
2018-05-14 Barth Jay (Chief Medical Officer) Option Ex 5,000 2.29 11,450
2018-04-17 Do Hung (Chief Science Officer) Sale 50,000 15.00 750,000
2018-04-16 Raab Michael (Director) Sale 5,000 14.41 72,060
2018-04-16 Raab Michael (Director) Option Ex 5,000 10.53 52,650
2018-04-12 Barth Jay (Chief Medical Officer) Sale 5,000 14.72 73,600
2018-04-12 Barth Jay (Chief Medical Officer) Option Ex 5,000 2.29 11,450
2018-04-02 Andrews Kurt J. (SVP, Human Resources) Sale 5,000 14.27 71,345
2018-04-02 Andrews Kurt J. (SVP, Human Resources) Option Ex 5,000 6.13 30,650
2018-04-02 Baird William D Iii (Chief Financial Officer) Sale 10,000 14.27 142,650
2018-04-02 Baird William D Iii (Chief Financial Officer) Option Ex 10,000 2.45 24,500
2018-03-12 Barth Jay (Chief Medical Officer) Sale 5,000 15.05 75,255
2018-03-12 Barth Jay (Chief Medical Officer) Option Ex 5,000 2.29 11,450
2018-03-09 Quimi Daphne (SVP, Finance) Sale 8,750 15.00 131,250
2018-03-09 Quimi Daphne (SVP, Finance) Option Ex 8,750 5.96 52,150
2018-03-05 Edelman Joseph (10% Owner) Buy 335,827 13.56 4,553,814
2018-03-02 Edelman Joseph (10% Owner) Buy 100,000 13.89 1,389,500
2018-03-01 Quimi Daphne (SVP, Finance) Sale 8,149 14.05 114,534
2018-03-01 Quimi Daphne (SVP, Finance) Option Ex 8,149 4.16 33,899
2018-03-01 Edelman Joseph (10% Owner) Buy 100,000 13.69 1,369,000
2018-01-23 Barth Jay (Chief Medical Officer) Sale 20,000 16.80 336,000
2018-01-23 Barth Jay (Chief Medical Officer) Option Ex 20,000 2.29 45,800
2018-01-22 Campbell Bradley L (Chief Operating Officer) Sale 32,500 15.92 517,367
2018-01-22 Campbell Bradley L (Chief Operating Officer) Option Ex 32,500 10.21 331,825
2018-01-02 Andrews Kurt J. (SVP, Human Resources) Sale 10,000 14.72 147,190
2018-01-02 Andrews Kurt J. (SVP, Human Resources) Option Ex 10,000 14.72 147,190
2018-01-02 Barth Jay (Chief Medical Officer) Sale 5,000 14.71 73,560
2018-01-02 Barth Jay (Chief Medical Officer) Option Ex 5,000 14.71 73,560
2018-01-02 Baird William D Iii (Chief Financial Officer) Sale 10,000 14.72 147,180
2018-01-02 Baird William D Iii (Chief Financial Officer) Option Ex 10,000 14.72 147,180
2018-01-02 Quimi Daphne (SVP, Finance) Sale 8,000 14.71 117,720
2018-01-02 Quimi Daphne (SVP, Finance) Option Ex 8,000 14.71 117,720
2018-01-02 Raab Michael (Director) Sale 9,366 15.00 140,490
2018-01-02 Raab Michael (Director) Option Ex 9,366 15.00 140,490
2018-01-02 Hayden Donald J Jr (Director) Sale 20,000 15.00 300,000
2018-01-02 Hayden Donald J Jr (Director) Option Ex 20,000 15.00 300,000
2017-12-29 Crowley John F (Chairman & CEO) Sale 5,920 14.75 87,320
2017-12-29 Crowley John F (Chairman & CEO) Option Ex 5,920 14.75 87,320
2017-12-28 Crowley John F (Chairman & CEO) Sale 13,050 14.75 192,500
2017-12-28 Crowley John F (Chairman & CEO) Option Ex 13,050 14.75 192,500
2017-12-21 Crowley John F (Chairman & CEO) Sale 506 13.51 6,835
2017-12-21 Crowley John F (Chairman & CEO) Option Ex 506 13.51 6,835
2017-12-20 Crowley John F (Chairman & CEO) Sale 65,075 13.51 878,902
2017-12-20 Crowley John F (Chairman & CEO) Option Ex 65,075 13.51 878,902
2017-12-11 Crowley John F (Chairman & CEO) Sale 12,206 13.52 164,976
2017-12-11 Crowley John F (Chairman & CEO) Option Ex 12,206 13.52 164,976
2017-12-04 Crowley John F (Chairman & CEO) Sale 47,213 13.61 642,757
2017-12-04 Crowley John F (Chairman & CEO) Option Ex 47,213 13.61 642,757
2017-12-01 Barth Jay (Chief Medical Officer) Sale 5,000 13.59 67,935
2017-12-01 Barth Jay (Chief Medical Officer) Option Ex 5,000 13.59 67,935
2017-10-18 Crowley John F (Chairman & CEO) Sale 19,013 14.76 280,536
2017-10-18 Crowley John F (Chairman & CEO) Option Ex 19,013 14.76 280,536
2017-10-17 Crowley John F (Chairman & CEO) Sale 52,722 14.75 777,649
2017-10-17 Crowley John F (Chairman & CEO) Option Ex 52,722 14.75 777,649
2017-10-16 Crowley John F (Chairman & CEO) Sale 47,135 14.75 695,241
2017-10-16 Crowley John F (Chairman & CEO) Option Ex 47,135 14.75 695,241
2017-10-13 Crowley John F (Chairman & CEO) Sale 22,160 14.75 326,860
2017-10-13 Crowley John F (Chairman & CEO) Option Ex 22,160 14.75 326,860
2017-10-12 Barth Jay (Chief Medical Officer) Sale 5,000 14.25 71,270
2017-10-12 Barth Jay (Chief Medical Officer) Option Ex 5,000 14.25 71,270
2017-10-12 Do Hung (Chief Science Officer) Sale 50,194 14.25 715,364
2017-10-12 Do Hung (Chief Science Officer) Option Ex 50,194 14.25 715,364
2017-10-12 Baird William D Iii (Chief Financial Officer) Sale 40,000 14.25 570,120
2017-10-12 Baird William D Iii (Chief Financial Officer) Option Ex 40,000 14.25 570,120
2017-10-12 Quimi Daphne (SVP, Finance) Sale 7,000 14.25 99,743
2017-10-12 Quimi Daphne (SVP, Finance) Option Ex 7,000 14.25 99,743
2017-10-12 Crowley John F (Chairman & CEO) Sale 380,000 14.25 5,415,000
2017-10-12 Crowley John F (Chairman & CEO) Option Ex 380,000 14.25 5,415,000
2017-10-12 Raab Michael (Director) Sale 10,000 14.25 142,530
2017-10-12 Raab Michael (Director) Option Ex 10,000 14.25 142,530
2017-09-26 Crowley John F (Chairman & CEO) Buy 1,395 14.36 20,032
2017-07-13 Edelman Joseph (10% Owner) Buy 1,500,000 12.25 18,375,000
2017-06-19 Barth Jay (Chief Medical Officer) Sale 30,000 10.00 300,000
2017-06-19 Barth Jay (Chief Medical Officer) Option Ex 30,000 10.00 300,000
2017-06-15 Barth Jay (Chief Medical Officer) Option Ex 1,629 8.79 14,318
2017-05-19 Do Hung (Chief Science Officer) Sale 29,914 8.00 239,312
2017-05-15 Do Hung (Chief Science Officer) Sale 29,914 8.00 239,312
2017-03-02 Campbell Bradley L (Chief Operating Officer) Sale 49,050 8.00 392,400
2017-02-07 Do Hung (Chief Science Officer) Sale 25,000 6.00 150,000
2017-01-13 Do Hung (Chief Science Officer) Sale 25,000 6.00 150,000
2017-01-03 Campbell Bradley L (Chief Operating Officer) Option Ex 100,000 .00 0
2016-12-30 Perceptive Life Sciences Master Fund Ltd Buy 94,750 4.96 470,054
2016-12-29 Perceptive Life Sciences Master Fund Ltd Buy 94,750 4.85 459,916
2016-12-28 Perceptive Life Sciences Master Fund Ltd Buy 47,375 4.91 232,706
2016-12-23 Perceptive Life Sciences Master Fund Ltd Buy 85,275 4.82 411,025
2016-12-22 Perceptive Life Sciences Master Fund Ltd Buy 189,500 4.51 854,834
2016-11-09 Quimi Daphne (SVP, Finance) Sale 8,546 8.00 68,368
2016-11-09 Quimi Daphne (SVP, Finance) Option Ex 2,858 8.00 22,864
2016-11-01 Do Hung (Chief Science Officer) Sale 25,000 7.00 175,000
2016-10-03 Do Hung (Chief Science Officer) Sale 25,000 7.25 181,250
2016-09-20 Baird William D Iii (Chief Financial Officer) Sale 20,500 8.00 164,041
2016-09-20 Baird William D Iii (Chief Financial Officer) Option Ex 3,500 8.00 28,000
2016-09-06 Do Hung (Chief Science Officer) Sale 25,000 7.00 175,000
2016-08-25 Perceptive Life Sciences Master Fund Ltd Sale 1,100,000 6.81 7,491,000
2016-08-04 Barth Jay (Chief Medical Officer) Sale 10,458 7.00 73,206
2016-08-04 Do Hung (Chief Science Officer) Sale 25,000 7.00 175,000
2016-07-27 Barth Jay (Chief Medical Officer) Sale 20,916 7.00 146,412
2016-06-03 Green Jeremy Buy 66,300 7.20 477,360
2016-06-02 Rosenberg Ellen (General Counsel & Corp. Secy) Buy 15,000 7.67 115,050
2016-01-04 Baird William D Iii (Chief Financial Officer) Option Ex 50,000 .00 0
2016-01-04 Quimi Daphne (Vice President Finance) Option Ex 25,000 .00 0
2016-01-04 Peist Kenneth (VP, Legal & IP) Option Ex 25,000 .00 0
2016-01-04 Campbell Bradley L (Chief Operating Officer) Option Ex 50,000 .00 0
2015-12-03 Barth Jay (Chief Medical Officer) Option Ex 25,000 .00 0
 1   2   3   4 

Insider trading activities including stock purchases, stock sales, and option exercises of FOLD listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Amicus Therapeutics, Inc. (symbol FOLD, CIK number 1178879) see the Securities and Exchange Commission (SEC) website.




Real-time Insider Trading

Insider Officer Cluster Trading

Top Officer Buys of the Week

Top Officer Buys of the Month